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Background: Congenital toxoplasmosis has a wide range of presentation at birth varying from severe neurological
features such as hydrocephalus and chorioretinitis to a well appearing baby, who may develop complications late
in infancy. While neuroendocrine abnormalities associated with congenital toxoplasmosis are uncommon, isolated
central diabetes insipidus is extremely rare.
Case presentation: Here, we report on a female infant who presented with fever, convulsions, and polyuria.
Examination revealed weight and length below the 3rd centile along with signs of severe dehydration. Fundal
examination showed bilateral chorioretinitis. This infant developed hypernatremia together with increased serum
osmolality and decreased both urine osmolality and specific gravity consistent with central diabetes insipidus.
Serology for toxoplasma specific immunoglobulin M was high for both the mother and the baby and polymerase
chain reaction for toxoplasma deoxyribonucleic acid was positive in the infant confirming congenital toxoplasmosis.
Brain computerized tomography scans demonstrated ventriculomegaly associated with cerebral and cortical
calcifications. Fluid and electrolyte abnormalities responded to nasal vasopressin therapy.
Conclusion: This report highlights central diabetes inspidus as a rare presentation of congenital toxoplasmosis.
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The incidence of maternal infection with Toxoplasma
gondii during pregnancy ranges from 1 to 8 per 1000 preg-
nancies [1]. The risk of vertical transmission of this obli-
gate intracellular parasite to the fetus increases with the
gestational age rising from less than 2% at 4 gestational
weeks to more than 80% at 36 weeks of pregnancy [1-4].
Congenital toxoplasmosis (CTox) is usually asymp-
tomatic. However, acute manifestations in the neonatal
period may occur including fever, anemia, jaundice, sei-
zure and hydrocephalus [5]. Few infants with CTox may
present with late sequel such as senso-neural deafness,
microcephaly and developmental delay. Infants with
CTox are usually treated with sulphadiazine, pyrimeth-
amine, and folinic acid for three months. Treatment may
be extended to one year depending on the severity of the
disease and the response to therapy [6].* Correspondence: sararmohamed@hotmail.com
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distribution, and reproduction in any mediumInvolvement of hypothalamic-pituitary axis is rarely
reported with CTox [7-11]. This usually affects the an-
terior pituitary and exceptionally the posterior pituitary.
We here report on an infant with congenital toxoplas-
mosis who presented with central diabetes insipidus (DI)
without other endocrine abnormalities involving the
hypothalamic pituitary axis.
Case presentation
A term baby girl was born to a 37-year-old Saudi
woman, with a birth weight of 2600 grams. The mother
had fever, body aches, and macular skin rash for a few
days in the 3rd trimester. Antenatal scan was normal,
and antenatal serology screening for congenital infec-
tions was not done. Six days after birth, the baby was
admitted with fever and convulsions, She was diagnosed
as neonatal sepsis, however; septic screening was unre-
markable including a negative blood culture. Similar sep-
sis like episodes with fever and convulsions recurred at 3
and 6 weeks of life, which were treated with intravenous
antibiotics, and the baby was discharged home in a good
condition. At the age of 3 months, the diagnosis of DItral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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polyuria (urine output was around 15 ml/kg/hr), severe
dehydration, and convulsion. Although systemic exami-
nation was normal at birth, she started to show up abnor-
mal neurological features by 3 months of age including:
bilateral nystagmus, significant head lag, hypertonia, brisk
reflexes, and extensor planter response, along with failure
to thrive. Examinations of the fundus showed bilateral
chorioretinitis.
Renal function showed normal urea and creatinine,
however; serum sodium was ranging between 147 and
150 mmol/L. Urine was diluted with urine osmolality
between 100 to 110 mosm/L (normal >600 mmol/L) and
she had low urine specific gravity of 1.005 (normal >
1.010). Thyroid function, growth hormone, luteinizing
hormone (LH), follicle stimulating hormone (FSH), adre-
nocorticotrophic hormone (ACTH) and cortisol were
within the normal limits (Table 1). Computerized
tomography (CT) of the brain demonstrated dilatedTable 1 Result of laboratory investigations for the infant
with congenital toxoplasmosis at 3 months of age
Lab work Result Reference value
WBC 5.6 × 10.e9/L 4.5-13.5
HGB 85 g/L 115-145






CSF WBC 14 < 5
Neutrophils 5%
Lymphocytes 95%
CSF protein 1240 mg/dl 25-40
CSF glucose 42 mg/dl 40-60
ACTH test 22.6 pg/mL 0-60
Cortisol AM 315 nmol/L 140-690
FT4 13.66 pmol/L 10.3-25.8
TSH 5.70 mIU/L 0.25-5
Alkaline Phosphatase 107 U/L <250
Alanine Aminotransferase 52 U/L 10-65
Aspartate Aminotransfer 23 U/L 10-31
Gamma Glutamyl Transpep. 99 U/L 5-55
Total Bilirubin 4 UMOL/L 2-17
Direct Bilirubin 0 UMOL/L 0
WBC: White cell count; HGB: Hemoglobin; PLT: Platelet; CSF: Cerebrospinal
fluid; ACTH: Adrenocorticotrophic hormone; FT4: Free thyroxine 4; TSH: Thyroid
stimulating hormone.ventricles with multiple subependymal and parenchymal
calcifications (Figure 1). Cerebrospinal (CSF) analysis
showed high protein and cells (Table 1). Electroence-
phalography (EEG) revealed multifocal epileptiform dis-
charges on diffusely slow background. Electroretinography
(ERG) illustrated evidence of retinopathy on the right eye.
Serology for toxoplasma specific immunoglobulin M
(IgM), performed for this infant at 3 month of age using
enzyme-linked immunosorbent assay (ELISA), was a
1370 unit/L (positive 120 (unit/L), and immunoglobulin
G (IgG) was a 11128 unit/L (positive > 110 unit/L). As
antenatal serology screening for congenital infection was
not done, maternal serology for toxoplasma IgM and
IgG was performed 3 month after delivery when CTox
was suspected. This result showed that maternal toxo-
plasma specific IgM was a 630 (positive 120 (unit/L),
and IgG was a 4320 unit/L (positive > 110 unit/L). Poly-
merase chain reaction (PCR) was positive for toxoplasma
deoxyribonucleic acid (DNA) in both CSF and blood
of the infant. The baby was commenced on pyrime-
thamine/sulphadiazine and leucovorin at 4 month of age
aiming to continue this treatment for 1 year. A favorable
response has been shown by regression of retinal lesions
after few weeks of starting antimicrobial treatment. Also,
she showed good response to nasal vasopressin with
urine output reduced to 3.2 ml/kg/hr, urine osmolality
increasing to 650 mosml/l and sodium controlledFigure 1 Computerized tomography of brain showing dilated
ventricles with multiple subependymal and parenchymal
calcifications (arrow).
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blood tests including complete blood count (CBC), liver
and renal functions showed satisfactory response to
treatment and absence of side effects of antimicrobial
therapy.
At age of 7 months and while still on pyrimethamine/
sulphadiazine and leucovorin, the baby developed
vesicular rash, high-grade fever, and convulsions. CBC
was normal and CSF examination revealed protein of
1120 mg/dl, glucose of 65 mg/dl and 20 cells, mostly
lymphocytes. CSF culture for bacteria as well as CSF
polymerase chain reaction for Toxoplasma gondii was
negative. Direct immunoflorescence test of a smear
taken from the vesicular rash was positive for varicella.
Based on this clinical data, in addition to having recent
contact with a family member with active chicken pox,
our patient was diagnosed as severe varicella meningo-
encephalitis. Compared to the previous images, CT brain
in this acute stage showed that hydrocephalus was not
progressive and hence ventriculoperitoneal shunt was
not inserted. This patient underwent extensive immune
work up including serum immunoglobulin, complement
and neutrophil function that failed to identify evidence
of immunodeficiency. She passed through a stormy
course, became comatose with intractable seizures, irre-
versible shock and severe metabolic acidosis. She died
despite full cardiorespiratory support with fluid, ino-
tropes, hydrocortisone and mechanical ventilation.
Discussion
Congenital toxoplasmosis (CTox) results from the trans-
placental passage of the Toxoplasma godii parasite from
the mother to the fetus. The majority of babies born to
mothers infected by this parasite are asymptomatic.
However, some babies present with variable clinical
manifestations including anemia, jaundice, hepatosple-
nomegaly, seizures, hydrocephalus, chorioretinitis and
senso-neural deafness. The severity of fetal damage de-
pend on the stage of pregnancy when maternal infection
occurs. Although she looked apparently normal at birth,
our patient presented in the neonatal period with non-
specific sepsis-like picture. Later she showed predo-
minant involvement of the central nervous system with
seizures, hydrocephalus, chorioretinitis and spasticity.
This clinical features alerted us to the possibility of
CTox, in which the detection of specific IgM or IgA
antibodies that cannot cross the placental barrier, is a
key marker of fetal infection. Moreover, prenatal diagno-
sis relies mostly on the PCR based detection of parasite
DNA. Unfortunately, this diagnostic approach was not
possible in this case as antenatal screening for congenital
infection is not routine practice in the hospital where
our patient was born. In the absence of this antenatal
serology data we performed anti-T gondii IgG and IgMby enzyme-linked immunosorbent assay (ELISA), which
was proved to be positive for both the infant and the
mother three months after delivery. This was an indirect
evidence of CTox, which was ultimately confirmed by
positive PCR for Toxoplasma in the infant. It is interes-
ting that IgG was elevated in both the infant and the
mother. It is expected that IgG synthesis reaches a plat-
eau within 2 or 3 months of the acute infection and then
decreases more or less rapidly and persists lifelong at
residual titers, which are highly variable among patients
[1]. As maternal IgG is passively transferred in utero,
therefore, a qualitative analysis is required to differenti-
ate between maternal antibodies and others synthesized
by the infected infant [1]. This was not needed in our
patient as IgM was positive that indicates infection.
Our patient presented with recurrent fever that can be
explained by dysfunction of the hypothalamic thermo-
regulatory center secondary to toxoplasma infection.
Fever could also result from dehydration caused by early
deficiency of antidiuretic hormone that was confirmed
later in the course of the disease. However, the serum
electrolyte pattern in the first episodes of fever was not
consistent with diabetes insipidus. Serum urea is usually
elevated in dehydrated children secondary to poor fee-
ding or fluid loss resulting from diarrhea and or vomit-
ing. Interestingly, serum urea is usually normal in
dehydrated patients with diabetes insipidus as in our
patient [12]. This results from defective reabsorption of
urea in the distal renal convoluted tubules that is nor-
mally facilitated by antidiuretic hormone. This useful
clinical clue should raise the suspicion of diabetes inspi-
dus in any child with unexplained dehydration and
normal serum urea.
CTox may affect the hypothalamic pituitary axis result-
ing in variable deficiencies of the anterior as well as the
posterior pituitary hormones. Isolated and selective defi-
ciency of the antidiuretic hormone as in our patient is
unusual. Massa et al. [8] reported three cases of CTox and
hypothalamic-pituitary dysfunction, all of whom presented
with different patterns of combined hormonal deficiency
(GH deficiency, diabetes insipidus, tertiary hypothyroidism,
adrenal insufficiency, and delayed puberty). Siahanidou
et al. [13] described a newborn similar to our patient, who
presented with prolonged fever and was confirmed later to
have central DI, hypothyroidism, and ACTH deficiency.
Few cases with isolated DI as the only endocrine abnor-
mality associated with CTox were described in the litera-
ture. Karadag et al. [14] reported a neonate with CTox and
hydrocephalus, who developed DI at the 10th day of life.
Similarly, Oygur et al. [15] presented a 33-day-old boy who
had polyuria, hypernatremia, and dehydration secondary to
central DI associated with CTox.
Although the diagnosis of DI was suspected late, our
patient responded nicely to nasal vasopressin with fluid
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ing replacement therapy [16]. Later, she had a stormy
acute course with most likely varicella meningoenceph-
alitis that led to her death. This working diagnosis is
supported by the typical rash, documented contact with
a relative with varicella, elevated CSF protein and cells,
in addition to the positive direct immunoflorescence
test for varicella. However, this diagnosis could have
been confirmed beyond doubt should varicella PCR has
been performed. Other possible explanation of this se-
vere disease was entertained such as immunodeficiency
and adrenal insufficiency, but none of these possibilities
was proven despite extensive workup. Nevertheless, our
patient was empirically covered with stress dose of
intravenous hydrocortisone during her acute illness.
The possibility of antimicrobial drug adverse effects was
considered, however; this event occurred 3 months after
starting treatment. Moreover, the rash was typical of
varicella infection.
Conclusion
Antenatal and newborn screening for CTox offers early
diagnosis and treatment of affected mother and infant
with specific antimicrobial therapy that leads to a better
outcome. This case report with severe manifestations of
CTox and delayed diagnosis of the disease highlights
the importance of antenatal and newborn screening for
toxoplasmosis, which is a feasible measure to minimize
the complications of CTox [1,4,5,17]. This report also
alerts physicians to central diabetes inspidus as a rare
presentation of CTox.
Consent
Written informed consent was obtained from the pa-
rents of the infant for publication of this Case Report
and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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